ASC Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD) (NCT04883918) | ASC Therapeutics | 2023-12-01 |
| ASC618 Gene Therapy in Hemophilia A Patients (NCT04676048) | ASC Therapeutics | 2022-08-03 |
Track ASC Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.